Detection of antibodies against SARS-CoV in serum from SARS-infected donors with ELISA and Western blot

Recombinant fragments of S proteins from the Severe Acute Respiratory Syndrome (SARS) coronavirus (SARA-CoV) were generated and used in a Western blot (WB) assay that was compared to a commercial SARS ELISA method. In 85% of confirmed SARS cases (n = 20), the S2 recombinant fragment based WB was pos...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 113(2004), 2 vom: 29. Nov., Seite 145-50
1. Verfasser: Wang, Yue-Dan (VerfasserIn)
Weitere Verfasser: Li, Yan, Xu, Guo-Bin, Dong, Xue-Yuan, Yang, Xiao-Ang, Feng, Zhen-Ru, Tian, Chan, Chen, Wei Feng
Format: Aufsatz
Sprache:English
Veröffentlicht: 2004
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Comparative Study Journal Article Research Support, Non-U.S. Gov't Antibodies Antibodies, Viral Membrane Glycoproteins Peptide Fragments Recombinant Proteins Spike Glycoprotein, Coronavirus Viral Envelope Proteins spike glycoprotein, SARS-CoV